Pharmaceutical composition and method of treating disease using a molecular complex assembled on astaxanthin core

MX2026005242APending Publication Date: 2026-10-02ADJUVIA THERAPEUTICS

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MX2026005242
Authority / Receiving Office: MX · MX
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2024-10-30
Filing Date: 2026-04-29
Publication Date: 2026-10-02

Application Information

Patent Timeline

30 Oct 2024

Priority

29 Apr 2026

Application

MX2026005242

02 Oct 2026

Publication

MX2026005242A

IPC: A61K36/05; A61K9/00; A61K31/215; A61K31/353; A61K45/06; A61K47/28; A61K47/32

CPC: A61K47/32; A61K36/05; A61K47/28; A61K31/353; A61K9/0053; A61K47/44; A61K45/06; A61K31/215

Inventors: GLICKMAN Laura H.; CARBERRY John

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

A pharmaceutical composition including a therapeutically effective amount of esterified 3S, 3'S trans astaxanthin in combination with one or more constituent ingredients assembled on a molecular core of the astaxanthin to increase bioavailability of the composition, and methods of treating disease by administering a therapeutically effective amount of the pharmaceutical composition to a patient.

Need to check novelty before this filing date? Find Prior Art